In November and December of 2009, Tylenol issued some broad recalls of a number of products including Arthritis Pain Caplets and varieties of Motrin, Rolaids and Benadryl due to a “moldy, musty smell” that caused mild illness in some people.
The FDA criticized Johnson & Johnson after the recall for dragging their feet on disclosing the risks to consumers:
“When something smells bad, literally and figuratively, you aggressively investigate and solve the problem,” said Deborah Autor, director of FDA’s compliance office.
“The company should have acted faster,” Autor said. “All companies have a responsibility to ensure high quality, safety and effectiveness of their products and protect consumers.”
Now Tylenol is recalling another group of medications, due to a spate of manufacturing defects:
Consumers should stop using certain lots of infants’ and children’s Tylenol, Motrin, Zyrtec and Benadryl products because some of them may contain too much of the active ingredient, McNeil said in a statement late Friday. Other products may contain tiny particles or inactive ingredients that may not meet testing requirements, the company said.
Included in the recall are infants’ and children’s pain and allergy suspension liquids:
Tylenol Infants’ Drops, Children’s Tylenol Suspensions, Infants’ Motrin Drops, Children’s Zyrtec liquid in bottles and Children’s Benadryl Allergy liquids in bottles.
Consumers who believe they may be in possession of recalled medications are advised to stop using the medications and may visit mcneilproductrecall.com for further information.